UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vaccine Therapies for Cancer: Then and Now

Targeted oncology, 2021-03, Vol.16 (2), p.121-152

2021

Volltextzugriff (PDF)

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Journal of clinical oncology, 2023-01, Vol.41 (2), p.198-205

2023

Volltextzugriff (PDF)

Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001662

2020

Volltextzugriff (PDF)

An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models

Breast cancer research : BCR, 2013-09, Vol.15 (5), p.R85-R85, Article R85

2013

Volltextzugriff (PDF)

A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype

Breast cancer research : BCR, 2014-07, Vol.16 (4), p.407-407, Article 407

2014

Volltextzugriff (PDF)

Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers

Breast cancer research : BCR, 2018-08, Vol.20 (1), p.90-90, Article 90

2018

Volltextzugriff (PDF)

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy

Oncoimmunology, 2017-04, Vol.6 (4), p.e1264563-e1264563

2017

Volltextzugriff (PDF)

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

Journal for immunotherapy of cancer, 2021-09, Vol.9 (9), p.e003122

2021

Volltextzugriff (PDF)

Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition

Oncoimmunology, 2017-06, Vol.6 (6), p.e1315495-e1315495

2017

Volltextzugriff (PDF)

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study

Clinical cancer research, 2017-09, Vol.23 (17), p.5066-5073

2017

Volltextzugriff (PDF)

TAILORing Estimates of Late Breast Cancer Recurrence with the RSClin Tool

NEJM evidence, 2024-08, Vol.3 (8)

2024

Volltextzugriff (PDF)

Pertuzumab protects the achilles' heel of trastuzumab--emtansine

Clinical cancer research, 2014-01, Vol.20 (2), p.278-280

2014

Volltextzugriff (PDF)

In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior

Clinical cancer research, 2017-12, Vol.23 (24), p.7531-7542

2017

Volltextzugriff (PDF)

CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine

Cancer chemotherapy and pharmacology, 2018-02, Vol.81 (2), p.365-372

2018

Volltextzugriff (PDF)

Immuno-Oncology in the Era of Personalized Medicine

Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics, 2019, Vol.1168, p.117-129

2019

Volltextzugriff (PDF)

Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors

Communications biology, 2020-05, Vol.3 (1), p.226-226, Article 226

2020

Volltextzugriff (PDF)

Vaccine-Induced Memory CD8 + T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Clinical cancer research, 2019-05, Vol.25 (9), p.2725-2736

2019

Volltextzugriff (PDF)

Incidental discovery of second primary malignancies in patients diagnosed with breast cancer: An institutional case series

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e12552-e12552

2023

Volltextzugriff (PDF)

A phase II study of concurrent WOKVAC vaccination with neoadjuvant chemotherapy and HER2-targeted monoclonal antibody therapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS636-TPS636

2023

Volltextzugriff (PDF)

Long term survival in patients with bony oligometastatic breast cancer treated with curative intent: An institutional case series

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e12574-e12574

2023

Volltextzugriff (PDF)

Matched FES and FDG PET imaging in patients with hormone receptor-positive, HER2+ advanced breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1042-1042

2022

Volltextzugriff (PDF)

A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2–positive breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.532-532

2023

Volltextzugriff (PDF)

A phase 2 study of HER3-DXd in patients (pts) with metastatic breast cancer (MBC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1004-1004

2023

Volltextzugriff (PDF)

Attamage-A1: Phase I/II study of autologous CD8+ and CD4+ transgenic t cells expressing high affinity MAGE-A1-specific T-cell receptor (TCR) combined with anti-PD(L)1 in patients with metastatic MAGE-A1 expressing cancer

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.TPS592-TPS592

2022

Volltextzugriff (PDF)

Pertuzumab Protects the Achilles1 Heel of Trastuzumab— Emtansine

Clinical cancer research, 2014, Vol.20 (2), p.278-280

2014

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Englisch
(44)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vaccine Therapies for Cancer: Then and Now

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio

An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models

A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype

Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study

TAILORing Estimates of Late Breast Cancer Recurrence with the RSClin Tool

Pertuzumab protects the achilles' heel of trastuzumab--emtansine

In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior

CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine

Immuno-Oncology in the Era of Personalized Medicine

Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors

Vaccine-Induced Memory CD8 + T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Incidental discovery of second primary malignancies in patients diagnosed with breast cancer: An institutional case series

A phase II study of concurrent WOKVAC vaccination with neoadjuvant chemotherapy and HER2-targeted monoclonal antibody therapy

Long term survival in patients with bony oligometastatic breast cancer treated with curative intent: An institutional case series

Matched FES and FDG PET imaging in patients with hormone receptor-positive, HER2+ advanced breast cancer

A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2–positive breast cancer

A phase 2 study of HER3-DXd in patients (pts) with metastatic breast cancer (MBC)

Attamage-A1: Phase I/II study of autologous CD8+ and CD4+ transgenic t cells expressing high affinity MAGE-A1-specific T-cell receptor (TCR) combined with anti-PD(L)1 in patients with metastatic MAGE-A1 expressing cancer

Pertuzumab Protects the Achilles1 Heel of Trastuzumab— Emtansine

Suchergebnisse filtern